Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Catalyst biosciences | Vintage Vibes

Looking Into Catalyst Biosciences's Return On Capital Employed

According to data from Benzinga Pro, during Q1, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $794.00 thousand. Despite a 28.5% increase in earnings, the company posted a loss of $14.54 million.

Benzinga · Jun 3, 2022

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue…

Benzinga · May 23, 2022

Why Catalyst Biosciences Shares Are Skyrocketing Today

Why Catalyst Biosciences Shares Are Skyrocketing Today

Catalyst Biosciences Inc (NASDAQ: CBIO) shares are trading higher by 180.26% at $1.06 after the company announced it sold its complement portfolio for $60 million.

Benzinga · May 23, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Catalyst Biosciences Q1 Earnings

Catalyst Biosciences (NASDAQ:CBIO) reported its Q1 earnings results on Monday, May 9, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga · May 9, 2022

Looking Into Catalyst Biosciences's Return On Capital Employed

According to data from Benzinga Pro, during Q4, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $2.44 million. Despite a 19.45% increase in earnings, the company posted a loss of $20.33 million.

Benzinga · Apr 1, 2022

1

Coverage From

Benzinga

Organisations

Vertex Pharmaceuticals Incorporated

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play